Search research articles
Contact Us
Filters
Showing results (61-70 of 96) with videos related to
Page
of 10
Sort By:
Circulation Journal : Official Journal of the Japanese Circulation Society
|
September 18, 2023
Polypharmacy and Bleeding Outcomes After Percutaneous Coronary Intervention
Ko Yamamoto, Takeshi Morimoto, Masahiro Natsuaki, et al.
BMJ Open
|
February 23, 2021
Demographics, practice patterns and long-term outcomes of patients with non-ST-segment elevation acute coronary syndrome in the past two decades: the CREDO-Kyoto Cohort-2 and Cohort-3
Yasuaki Takeji, Hiroki Shiomi, Takeshi Morimoto, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
May 17, 2023
Dual Antiplatelet Therapy Duration After Multivessel Optimal Intravascular Ultrasound-Guided Percutaneous Coronary Intervention
Ko Yamamoto, Hiroki Shiomi, Takeshi Morimoto, et al.
The American Journal of Cardiology
|
September 26, 2025
Optimal Intravascular Ultrasound-Guided Percutaneous Coronary Intervention in Patients With Left Main Coronary Artery Disease: The OPTIVUS-Complex PCI Study LMCA Cohort
Ryusuke Nishikawa, Hiroki Shiomi, Ko Yamamoto, et al.
The American Journal of Cardiology
|
September 3, 2023
SYNTAX Score and 1-Year Outcomes in the OPTIVUS-Complex PCI Study Multivessel Cohort
Masaomi Gohbara, Kiyoshi Hibi, Takeshi Morimoto, et al.
Cardiovascular Intervention and Therapeutics
|
April 6, 2025
Complex PCI and 1-year outcomes in the OPTIVUS-complex PCI study multivessel cohort
Masaomi Gohbara, Kiyoshi Hibi, Takeshi Morimoto, et al.
The American Journal of Cardiology
|
September 9, 2021
Effect of Polypharmacy on Long-Term Mortality After Percutaneous Coronary Intervention
Ko Yamamoto, Masahiro Natsuaki, Takeshi Morimoto, et al.
JAMA Cardiology
|
March 2, 2022
Comparison of Clopidogrel Monotherapy After 1 to 2 Months of Dual Antiplatelet Therapy With 12 Months of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome: The STOPDAPT-2 ACS Randomized Clinical Trial
Hirotoshi Watanabe, Takeshi Morimoto, Masahiro Natsuaki, et al.
JACC. Asia
|
August 24, 2023
Single-Session Versus Staged Multivessel Optimal IVUS-Guided PCI in Patients With CCS or NSTE-ACS
Ko Yamamoto, Hiroki Shiomi, Takeshi Morimoto, et al.
The American Journal of Cardiology
|
January 17, 2021
Percutaneous Coronary Intervention Versus Coronary Artery Bypass Graftinge Among Patients with Unprotected Left Main Coronary Artery Disease in the New-Generation Drug-Eluting Stents Era (From the CREDO-Kyoto PCI/CABG Registry Cohort-3)
Ko Yamamoto, Hiroki Shiomi, Takeshi Morimoto, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 96) with videos related to
Sort By:
Page
of 10
Circulation Journal : Official Journal of the Japanese Circulation Society
|
September 18, 2023
Polypharmacy and Bleeding Outcomes After Percutaneous Coronary Intervention
Ko Yamamoto, Takeshi Morimoto, Masahiro Natsuaki, et al.
BMJ Open
|
February 23, 2021
Demographics, practice patterns and long-term outcomes of patients with non-ST-segment elevation acute coronary syndrome in the past two decades: the CREDO-Kyoto Cohort-2 and Cohort-3
Yasuaki Takeji, Hiroki Shiomi, Takeshi Morimoto, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
May 17, 2023
Dual Antiplatelet Therapy Duration After Multivessel Optimal Intravascular Ultrasound-Guided Percutaneous Coronary Intervention
Ko Yamamoto, Hiroki Shiomi, Takeshi Morimoto, et al.
The American Journal of Cardiology
|
September 26, 2025
Optimal Intravascular Ultrasound-Guided Percutaneous Coronary Intervention in Patients With Left Main Coronary Artery Disease: The OPTIVUS-Complex PCI Study LMCA Cohort
Ryusuke Nishikawa, Hiroki Shiomi, Ko Yamamoto, et al.
The American Journal of Cardiology
|
September 3, 2023
SYNTAX Score and 1-Year Outcomes in the OPTIVUS-Complex PCI Study Multivessel Cohort
Masaomi Gohbara, Kiyoshi Hibi, Takeshi Morimoto, et al.
Cardiovascular Intervention and Therapeutics
|
April 6, 2025
Complex PCI and 1-year outcomes in the OPTIVUS-complex PCI study multivessel cohort
Masaomi Gohbara, Kiyoshi Hibi, Takeshi Morimoto, et al.
The American Journal of Cardiology
|
September 9, 2021
Effect of Polypharmacy on Long-Term Mortality After Percutaneous Coronary Intervention
Ko Yamamoto, Masahiro Natsuaki, Takeshi Morimoto, et al.
JAMA Cardiology
|
March 2, 2022
Comparison of Clopidogrel Monotherapy After 1 to 2 Months of Dual Antiplatelet Therapy With 12 Months of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome: The STOPDAPT-2 ACS Randomized Clinical Trial
Hirotoshi Watanabe, Takeshi Morimoto, Masahiro Natsuaki, et al.
JACC. Asia
|
August 24, 2023
Single-Session Versus Staged Multivessel Optimal IVUS-Guided PCI in Patients With CCS or NSTE-ACS
Ko Yamamoto, Hiroki Shiomi, Takeshi Morimoto, et al.
The American Journal of Cardiology
|
January 17, 2021
Percutaneous Coronary Intervention Versus Coronary Artery Bypass Graftinge Among Patients with Unprotected Left Main Coronary Artery Disease in the New-Generation Drug-Eluting Stents Era (From the CREDO-Kyoto PCI/CABG Registry Cohort-3)
Ko Yamamoto, Hiroki Shiomi, Takeshi Morimoto, et al.
Page
of 10